{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:58:54Z","timestamp":1780941534035,"version":"3.54.1"},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01-DA049843-01S1"],"award-info":[{"award-number":["R01-DA049843-01S1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30-AI073961"],"award-info":[{"award-number":["P30-AI073961"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F32-AI162229"],"award-info":[{"award-number":["F32-AI162229"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["P30-MH133399"],"award-info":[{"award-number":["P30-MH133399"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    People with HIV (PWH) experience elevated cardiovascular disease risk compared to people without HIV. Stimulant use may further increase subclinical myocardial injury among PWH, but data on cardiovascular biomarkers, including serum high-sensitivity cardiac troponin T (hs-cTnT) in this population is limited. This cross-sectional secondary analysis included 72 cisgender men with and without HIV enrolled in a South Florida cohort. Stimulant exposure was defined as any non-prescribed stimulant use in the past 3 months and\/or a reactive urine toxicology screen, creating four HIV-by-stimulant use groups (i.e., HIV+Stim\u2009+\u2009, HIV+Stim-, HIV-Stim\u2009+\u2009, and HIV-Stim-). hs-cTnT was measured using a Roche high-sensitivity assay, with values below the limit of detection treated as undetectable. We used a two-part model (logistic for detectability; log-normal among participants with detectable hs-cTnT), adjusted for age and recent tobacco use, with sensitivity analyses adding renal function and cardiometabolic factors. After adjusting for age and recent tobacco use, HIV+Stim+ participants had higher odds of detectable hs-cTnT (aOR = 7.48, 95% CI: 1.25, 44.62) and higher estimated mean concentration of hs-cTnT (\u03b2\u2009=\u20090.51,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.031,\n                    <jats:italic>mean<\/jats:italic>\n                    \u2009=\u200912) than the HIV-Stim- group. Exploratory analyses suggested a positive dose-response association between amphetamine metabolite levels and hs-cTnT (\n                    <jats:italic>r<\/jats:italic>\n                    (11) = 0.86,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Co-occurring HIV and stimulant use were associated with higher hs-cTnT in this sample. However, given that hs-cTnT may reflect a range of acute, subacute, and chronic processes, and the small sample size and restricted generalizability, these findings should be interpreted as exploratory and hypothesis-generating and require confirmation in larger studies.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0350086","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:23:52Z","timestamp":1780939432000},"page":"e0350086","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated high sensitivity cardiac troponin T among men with HIV who use stimulants: A cross-sectional study of subclinical cardiovascular injury"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1821-1239","authenticated-orcid":true,"given":"Michaela E.","family":"Larson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-0975","authenticated-orcid":true,"given":"Yue","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Reidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Cherenack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Hirshfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith J.","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise D.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Pahwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Pallikkuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2489-6193","authenticated-orcid":true,"given":"Claudia","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam W.","family":"Carrico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"6","key":"pone.0350086.ref001","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/hiv.13077","article-title":"The burden of non-communicable diseases and mortality in people living with HIV (PLHIV) in the pre-, early- and late-HAART era","volume":"22","author":"NA Jespersen","year":"2021","journal-title":"HIV Med"},{"key":"pone.0350086.ref002","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000001478","article-title":"Clinical implications of aging with HIV infection: perspectives and the future medical care agenda","volume":"31","author":"G Guaraldi","year":"2017","journal-title":"AIDS"},{"issue":"12","key":"pone.0350086.ref003","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/QAD.0000000000001870","article-title":"Achieving the fourth 90: healthy aging for people living with HIV","volume":"32","author":"TG Harris","year":"2018","journal-title":"AIDS"},{"key":"pone.0350086.ref004","article-title":"Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis","author":"P Patel","year":"2018","journal-title":"AIDS"},{"issue":"2","key":"pone.0350086.ref005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/QAI.0000000000000419","article-title":"HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction","volume":"68","author":"A-L Paisible","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"pone.0350086.ref006","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"MS Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"21","key":"pone.0350086.ref007","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009985","article-title":"Adjudicated heart failure in HIV-infected and uninfected men and women","volume":"7","author":"MJ Feinstein","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"pone.0350086.ref008","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American heart association","volume":"140","author":"MJ Feinstein","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"pone.0350086.ref009","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis","volume":"138","author":"ASV Shah","year":"2018","journal-title":"Circulation"},{"key":"pone.0350086.ref010","doi-asserted-by":"crossref","DOI":"10.5830\/CVJA-2015-036","article-title":"Mortality from cardiovascular diseases in sub-Saharan Africa, 1990\u20132013: a systematic analysis of data from the Global Burden of Disease Study 2013","volume":"26","author":"GA Mensah","year":"2015","journal-title":"Cardiovasc J Afr"},{"key":"pone.0350086.ref011","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","author":"FJJ Palella","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"pone.0350086.ref012","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.118.036211","article-title":"Time to recognize HIV infection as a major cardiovascular risk factor","volume":"138","author":"PY Hsue","year":"2018","journal-title":"Circulation"},{"issue":"25","key":"pone.0350086.ref013","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.jacc.2017.05.012","article-title":"HIV-1-associated atherosclerosis: unraveling the missing link","volume":"69","author":"A Kearns","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"pone.0350086.ref014","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S2213-8587(15)00388-5","article-title":"Pathophysiology and management of cardiovascular disease in patients with HIV","volume":"4","author":"E Nou","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"pone.0350086.ref015","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41569-019-0219-9","article-title":"HIV infection and coronary heart disease: mechanisms and management","volume":"16","author":"PY Hsue","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"pone.0350086.ref016","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.tcm.2017.06.005","article-title":"Cardiovascular disease in patients with HIV","volume":"27","author":"F Ballocca","year":"2017","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"pone.0350086.ref017","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jacc.2016.09.979","article-title":"HIV and ischemic heart disease","volume":"69","author":"A Vachiat","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"pone.0350086.ref018","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.30795","article-title":"Assessment of stimulant use and cardiovascular event risks among older adults","volume":"4","author":"M Tadrous","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"pone.0350086.ref019","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2017.05.014","article-title":"The cardiovascular effects of cocaine","volume":"70","author":"O Havakuk","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"pone.0350086.ref020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.hlc.2015.10.019","article-title":"The Cardiac Complications of Methamphetamines","volume":"25","author":"ED Paratz","year":"2016","journal-title":"Heart Lung Circ"},{"issue":"6","key":"pone.0350086.ref021","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jchf.2017.02.017","article-title":"Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy","volume":"5","author":"S Sch\u00fcrer","year":"2017","journal-title":"JACC Heart Fail"},{"key":"pone.0350086.ref022","doi-asserted-by":"crossref","first-page":"109132","DOI":"10.1016\/j.drugalcdep.2021.109132","article-title":"Risk of cardiovascular diseases in relation to substance use disorders","volume":"229","author":"WQ Gan","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"pone.0350086.ref023","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/med.21476","article-title":"Comprehensive review of cardiovascular toxicity of drugs and related agents","volume":"38","author":"P Mlad\u011bnka","year":"2018","journal-title":"Med Res Rev"},{"issue":"7","key":"pone.0350086.ref024","article-title":"Epidemiology, burden, and association of substance abuse amongst patients with cardiovascular disorders: national cross-sectional survey study","volume":"14","author":"N Chelikam","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"pone.0350086.ref025","article-title":"Effects of substance use disorder on in-hospital outcomes of young patients presenting with a cardiovascular event: a nationwide analysis","volume":"14","author":"A Brgdar","year":"2022","journal-title":"Cureus"},{"issue":"8","key":"pone.0350086.ref026","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2105\/AJPH.2012.301162","article-title":"Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort","volume":"103","author":"MJ Mimiaga","year":"2013","journal-title":"Am J Public Health"},{"issue":"1","key":"pone.0350086.ref027","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s10461-011-0124-7","article-title":"Association between use of specific drugs and antiretroviral adherence: findings from MACH 14","volume":"17","author":"MI Rosen","year":"2013","journal-title":"AIDS Behav"},{"key":"pone.0350086.ref028","author":"NIH Office of AIDS Research","year":"2021"},{"key":"pone.0350086.ref029","volume-title":"Behavioral and clinical characteristics of persons with diagnosed HIV infection\u2014Medical monitoring project, United States 2021 cycle (June 2021\u2013May 2022)","author":"Centers for Disease Control and Prevention","year":"2019"},{"issue":"5","key":"pone.0350086.ref030","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.amepre.2020.05.025","article-title":"Medical, nonmedical, and illegal stimulant use by sexual identity and gender","volume":"59","author":"MM Philbin","year":"2020","journal-title":"Am J Prev Med"},{"issue":"12","key":"pone.0350086.ref031","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1086\/379894","article-title":"Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy","volume":"188","author":"RJ Ellis","year":"2003","journal-title":"J Infect Dis"},{"issue":"8","key":"pone.0350086.ref032","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bbi.2008.07.010","article-title":"Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy","volume":"22","author":"AW Carrico","year":"2008","journal-title":"Brain Behav Immun"},{"key":"pone.0350086.ref033","doi-asserted-by":"crossref","first-page":"13179","DOI":"10.1038\/srep13179","article-title":"Methamphetamine use in HIV-infected individuals affects T-cell function and viral outcome during suppressive antiretroviral therapy","volume":"5","author":"M Massanella","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0350086.ref034","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QAI.0b013e3181900129","article-title":"Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users","volume":"50","author":"MK Baum","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"pone.0350086.ref035","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/QAD.0b013e32830507f2","article-title":"Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women","volume":"22","author":"JA Cook","year":"2008","journal-title":"AIDS"},{"issue":"1","key":"pone.0350086.ref036","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10974-019-09513-1","article-title":"Troponin structure and function: a view of recent progress","volume":"41","author":"S Marston","year":"2020","journal-title":"J Muscle Res Cell Motil"},{"issue":"4","key":"pone.0350086.ref037","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/01.RES.76.4.681","article-title":"Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart","volume":"76","author":"PA Anderson","year":"1995","journal-title":"Circ Res"},{"issue":"12","key":"pone.0350086.ref038","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1373\/clinchem.2009.130799","article-title":"Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure","volume":"55","author":"WE Kelley","year":"2009","journal-title":"Clin Chem"},{"issue":"2","key":"pone.0350086.ref039","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18773\/austprescr.2022.006","article-title":"Troponins in myocardial infarction and injury","volume":"45","author":"JM Potter","year":"2022","journal-title":"Aust Prescr"},{"issue":"3","key":"pone.0350086.ref040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090063","article-title":"Comparison of three troponins as predictors of future cardiovascular events--prospective results from the FINRISK and BiomaCaRE studies","volume":"9","author":"JT Neumann","year":"2014","journal-title":"PLoS One"},{"issue":"30","key":"pone.0350086.ref041","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/eurheartj\/ehw172","article-title":"Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium","volume":"37","author":"S Blankenberg","year":"2016","journal-title":"Eur Heart J"},{"key":"pone.0350086.ref042","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jacc.2022.10.017","article-title":"Implementation of high-sensitivity cardiac troponin assays in the United States","volume":"81","author":"C McCarthy","year":"2023","journal-title":"J Am College Cardiol"},{"issue":"10","key":"pone.0350086.ref043","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2021.01.011","article-title":"A test in context: interpretation of high-sensitivity cardiac troponin assays in different clinical settings","volume":"77","author":"I Raber","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"pone.0350086.ref044","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1373\/jalm.2018.028860","article-title":"Association of high-sensitivity troponin with cardiac CT angiography evidence of myocardial and coronary disease in a primary prevention cohort of men: results from MACS","volume":"4","author":"F Rahman","year":"2019","journal-title":"J Appl Lab Med"},{"issue":"7","key":"pone.0350086.ref045","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad234","article-title":"High-sensitivity troponins and subclinical coronary atherosclerosis evaluated by coronary calcium score among older asians living with well-controlled human immunodeficiency virus","volume":"10","author":"P Chattranukulchai","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"pone.0350086.ref046","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S0735-1097(22)02621-3","article-title":"Associations between high sensitivity troponin levels, HIV serostatus and cardiac MRI measures","volume":"79","author":"A Jefferson","year":"2022","journal-title":"J Am College Cardiol"},{"issue":"6","key":"pone.0350086.ref047","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062352","article-title":"Cardiovascular risk factors and markers of myocardial injury and inflammation in people living with HIV in Nairobi, Kenya: a pilot cross-sectional study","volume":"12","author":"HA Ahmed","year":"2022","journal-title":"BMJ Open"},{"issue":"3","key":"pone.0350086.ref048","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0956462418800873","article-title":"Circulating levels of cardiac troponin T are associated with coronary noncalcified plaque burden in HIV-infected adults: a pilot study","volume":"30","author":"P Foster","year":"2019","journal-title":"Int J STD AIDS"},{"key":"pone.0350086.ref049","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2016.11.039","article-title":"Higher prevalence of detectable troponin I among cocaine-users without known cardiovascular disease","volume":"172","author":"ED Riley","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"pone.0350086.ref050","doi-asserted-by":"crossref","first-page":"108252","DOI":"10.1016\/j.drugalcdep.2020.108252","article-title":"Impact of polysubstance use on high-sensitivity cardiac troponin I over time in homeless and unstably housed women","volume":"217","author":"ED Riley","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"pone.0350086.ref051","doi-asserted-by":"crossref","first-page":"110942","DOI":"10.1016\/j.drugalcdep.2023.110942","article-title":"Stimulant use, HIV, and immune dysregulation among sexual minority men","volume":"251","author":"EM Cherenack","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"pone.0350086.ref052","author":"Redwood Toxicology Laboratory","year":"2023"},{"issue":"9","key":"pone.0350086.ref053","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1046\/j.1360-0443.2002.00185.x","article-title":"The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility","volume":"97","author":"WHO ASSIST Working Group","year":"2002","journal-title":"Addiction"},{"key":"pone.0350086.ref054","volume-title":"OraQuick advanced HIV 1\/2 antibody test. Bethlehem, Pennsylvania","author":"Orasure Technologies, Inc","year":"2006"},{"issue":"4","key":"pone.0350086.ref055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jcv.2010.01.008","article-title":"Viral load assay sensitivity and low level viremia in HAART treated HIV patients","volume":"47","author":"C Verhofstede","year":"2010","journal-title":"J Clin Virol"},{"key":"pone.0350086.ref056","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2017.02.003","article-title":"Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: a meta-analysis","volume":"259","author":"Y Li","year":"2017","journal-title":"Atherosclerosis"},{"issue":"8","key":"pone.0350086.ref057","first-page":"439","article-title":"High-sensitivity C-reactive protein: clinical importance","volume":"29","author":"SS Bassuk","year":"2004","journal-title":"Curr Probl Cardiol"},{"issue":"3","key":"pone.0350086.ref058","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/clinchem\/47.3.403","article-title":"High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease","volume":"47","author":"N Rifai","year":"2001","journal-title":"Clin Chem"},{"issue":"15","key":"pone.0350086.ref059","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.CIR.0000015464.18023.0A","article-title":"Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes","volume":"105","author":"MS Sabatine","year":"2002","journal-title":"Circulation"},{"key":"pone.0350086.ref060","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"K Thygesen","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"pone.0350086.ref061","first-page":"305","article-title":"Clinical importance of high- sensitivity troponin T in patients without coronary artery disease","volume":"7","author":"L Askin","year":"2020","journal-title":"North Clin Istanb"},{"issue":"3","key":"pone.0350086.ref062","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/infdis\/jiy183","article-title":"Acute HIV infection results in subclinical inflammatory cardiomyopathy","volume":"218","author":"C Schuster","year":"2018","journal-title":"J Infect Dis"},{"issue":"6","key":"pone.0350086.ref063","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/QAD.0000000000001751","article-title":"Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection","volume":"32","author":"AW Carrico","year":"2018","journal-title":"AIDS"},{"key":"pone.0350086.ref064","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbi.2018.04.004","article-title":"Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection","volume":"71","author":"AW Carrico","year":"2018","journal-title":"Brain Behav Immun"},{"issue":"1","key":"pone.0350086.ref065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11481-018-9797-2","article-title":"Psychosocial correlates of monocyte activation and HIV persistence in methamphetamine users","volume":"14","author":"K Grosgebauer","year":"2019","journal-title":"J Neuroimmune Pharmacol"},{"issue":"15","key":"pone.0350086.ref066","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.CIR.0000015464.18023.0A","article-title":"Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide","volume":"105","author":"MS Sabatine","year":"2002","journal-title":"Circulation"},{"issue":"7","key":"pone.0350086.ref067","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0735-1097(98)00136-3","article-title":"C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction","volume":"31","author":"DA Morrow","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"pone.0350086.ref068","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/CIRCULATIONAHA.107.188950","article-title":"Management of cocaine-associated chest pain and myocardial infarction","volume":"117","author":"J McCord","year":"2008","journal-title":"Circulation"},{"issue":"11","key":"pone.0350086.ref069","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0735-1097(17)33670-7","article-title":"Association of cocaine and amphetamine use with troponin I concentrations","volume":"69","author":"P Moore","year":"2017","journal-title":"J Am College Cardiol"},{"issue":"1","key":"pone.0350086.ref070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ijnp\/pyac069","article-title":"Association between inflammatory cytokines, executive function, and substance use in patients with opioid use disorder and amphetamine-type stimulants use disorder","volume":"26","author":"T-Y Wang","year":"2023","journal-title":"Int J Neuropsychopharmacol"},{"key":"pone.0350086.ref071","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drugalcdep.2018.02.015","article-title":"Effect of methamphetamine exposure on the plasma levels of endothelial-derived microparticles","volume":"186","author":"A Nazari","year":"2018","journal-title":"Drug Alcohol Depend"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:24:02Z","timestamp":1780939442000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350086"}},"subtitle":[],"editor":[{"given":"Michele","family":"Golino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":71,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350086","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]}}}